Correlation between Helicobacter pylori infection and Crohn's disease: a meta-analysis

W-L Wang1, X-J Xu

  • 1Department of Gastroenterology, Jiaxing Traditional Chinese Medicine Hospital, Jiaxing, China. gracewwl@163.com.

Insights

Helicobacter pylori (Hp) infection appears to be a protective factor against Crohn's disease (CD). Further research is needed to confirm this negative correlation and understand its implications for inflammatory bowel disease pathogenesis.

Area of Science:

  • Gastroenterology
  • Microbiology
  • Immunology

Background:

  • The relationship between Helicobacter pylori (Hp) infection and Crohn's disease (CD) remains debated.
  • Understanding this association may offer insights into the pathogenesis of inflammatory bowel diseases (IBD).

Purpose of the Study:

  • To investigate the correlation between Hp infection and CD susceptibility.
  • To provide a theoretical basis for IBD pathogenesis research.

Main Methods:

  • A systematic literature review was conducted using Medline, PubMed, and Cochrane databases (1991-2019).
  • Data from 20 studies (2055 CD patients, 3442 controls) were analyzed for odds ratio (OR) and 95% confidence interval (CI).

Main Results:

  • The prevalence of Hp infection was lower in CD patients (30.6%) compared to controls (42.7%).
  • A significant negative correlation was observed between Hp infection and CD [OR=0.42, 95% CI (0.33-0.54), p<0.00001].
  • Significant heterogeneity was noted among the included studies.

Conclusions:

  • Hp infection may act as a protective factor against the development of Crohn's disease.
  • Heterogeneity and potential publication bias warrant caution in interpreting these findings.
  • Additional research is essential to elucidate the precise influence of Hp infection on CD.
Abstract

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
997
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
488
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.0K
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
689
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
1.8K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.1K